Moreover, statistical analysis of gene data from the TCGA database confirmed that the expression trend of CAV1 in breast cancer tissues was consistent with that of CD36, with CAV1 expression significantly lower in cancer tissues compared with normal tissues (Figure 5E). This evidence concerns the gene CAV1 and breast carcinoma.